Literature DB >> 12149526

Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma.

N G Carroll1, S Mutavdzic, A L James.   

Abstract

BACKGROUND: Mucus plugging of the airways is invariably seen in cases of fatal asthma, mucus production is associated with asthma attacks, and the area of submucosal glands is increased in asthma. Mediators secreted from mast cells and neutrophils can stimulate mucous gland secretion. A study was undertaken to count the mast cells and neutrophils in submucosal glands and to relate cell numbers to the presence of mucus in the airway lumen.
METHODS: Cartilaginous airways obtained at necropsy from cases of fatal asthma (n=8), non-fatal asthma (n=8), and control cases (n=8) were examined. Contiguous transverse sections were stained for mast cell tryptase and neutrophil elastase, and with Periodic Acid Schiff solution to identify mucus. Mucous gland area, lumen area, and the percentage of the relaxed lumen area occupied by mucus (mucus occupying ratio, MOR) were measured. Mast cells (intact and degranulated) and neutrophils per area of submucosal gland were calculated.
RESULTS: Compared with controls, the cases of fatal asthma had increased mucous gland area, MOR, percentage of degranulated mast cells, and numbers of neutrophils in the submucosal glands (p<0.05). In cases of non-fatal asthma the MOR and the numbers of mast cells and neutrophils in the submucosal glands were increased (p<0.05). When all cases were pooled together, the MOR correlated with the total number of mast cells (r=0.55, p=0.005) and with the number of degranulated mast cells in the submucosal glands (r=0.51, p=0.013), but not with the number of neutrophils (r=0.21, p=0.121).
CONCLUSION: These results show that mucous gland area, MOR, and mucous gland inflammation are increased in asthma and that degranulation of mast cells may contribute to secretion of mucus into the lumen in cases of fatal asthma.

Entities:  

Mesh:

Year:  2002        PMID: 12149526      PMCID: PMC1746401          DOI: 10.1136/thorax.57.8.677

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  The pathology of asthma, with special reference to changes in the bronchial mucosa.

Authors:  M S DUNNILL
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

2.  Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study.

Authors:  P K Jeffery; R W Godfrey; E Adelroth; F Nelson; A Rogers; S A Johansson
Journal:  Am Rev Respir Dis       Date:  1992-04

3.  Role of mast cell and neutrophil proteases in airway secretion.

Authors:  J A Nadel
Journal:  Am Rev Respir Dis       Date:  1991-09

4.  Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma.

Authors:  M Saetta; A Di Stefano; C Rosina; G Thiene; L M Fabbri
Journal:  Am Rev Respir Dis       Date:  1991-01

5.  Some histological changes in chronic bronchitis and asthma.

Authors:  G Salvato
Journal:  Thorax       Date:  1968-03       Impact factor: 9.139

6.  Asthmatic deaths. Role of the mast cell.

Authors:  J T Connell
Journal:  JAMA       Date:  1971-02-01       Impact factor: 56.272

7.  The mechanics of airway narrowing in asthma.

Authors:  A L James; P D Paré; J C Hogg
Journal:  Am Rev Respir Dis       Date:  1989-01

8.  Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack.

Authors:  T Aikawa; S Shimura; H Sasaki; M Ebina; T Takishima
Journal:  Chest       Date:  1992-04       Impact factor: 9.410

9.  Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma.

Authors:  R Djukanović; J W Wilson; K M Britten; S J Wilson; A F Walls; W R Roche; P H Howarth; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1992-03

10.  Reassessment of inflammation of airways in chronic bronchitis.

Authors:  J B Mullen; J L Wright; B R Wiggs; P D Pare; J C Hogg
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-02
View more
  43 in total

1.  The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo.

Authors:  Sarah J Collington; Jenny Hallgren; James E Pease; Tatiana G Jones; Barrett J Rollins; John Westwick; K Frank Austen; Timothy J Williams; Michael F Gurish; Charlotte L Weller
Journal:  J Immunol       Date:  2010-04-28       Impact factor: 5.422

Review 2.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

3.  The role of IL-33/ST2, IL-4, and eosinophils on the airway hyperresponsiveness induced by Strongyloides venezuelensis in BALB/c mice.

Authors:  Emilia Souza Araujo; Cintia Aparecida de Jesus Pereira; Ana Terezinha de Moura Pereira; João Marcelo Peixoto Moreira; Michelle Carvalho de Rezende; Jailza Lima Rodrigues; Mauro Martins Teixeira; Deborah Negrão-Corrêa
Journal:  Parasitol Res       Date:  2016-04-22       Impact factor: 2.289

4.  Potential Role of Mast Cells in Regulating Corticosteroid Insensitivity in Severe Asthma.

Authors:  Abdulrahman Alzahrani; Aamir Hussain; Fahad Alhadian; Jameel Hakeem; Sana Douaoui; Omar Tliba; Peter Bradding; Yassine Amrani
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  The critically ill asthmatic--from ICU to discharge.

Authors:  Samuel Louie; Brian M Morrissey; Nicholas J Kenyon; Timothy E Albertson; Mark Avdalovic
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

6.  The function of CCR3 on mouse bone marrow-derived mast cells in vitro.

Authors:  Sarah J Collington; John Westwick; Timothy J Williams; Charlotte L Weller
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

7.  Asthma: eosinophil disease, mast cell disease, or both?

Authors:  Peter Bradding
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

8.  Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.

Authors:  S Saha; V Mistry; R Siva; D Parker; R May; P Bradding; I D Pavord; C E Brightling
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

9.  Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.

Authors:  S Mark Duffy; Glenn Cruse; Christopher E Brightling; Peter Bradding
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

10.  Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration.

Authors:  S Mark Duffy; Glenn Cruse; Sarah L Cockerill; Chris E Brightling; Peter Bradding
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.